Cells cultured from human giant cell tumors of bone were characterized on the basis of morphological features, proliferative capacity, presence of granulocyte-monocyte antigens, receptors for skeletal hormones, and soluble cell products. Three major cell types were identified. One population consisted of mononuclear cells with fibroblastic morphology, which proliferated in culture and most likely represent the neoplastic element of the tumor. 
Introduction
Giant cell tumors of bone are relatively uncommon tumors of skeletal tissue that produce expansile well delineated lytic lesions (1) (2) (3) (4) (5) (6) . These tumors are characterized by the presence of large multinucleated giant cells distributed among distinctive stromal cells. The histochemical and ultrastructural features ofthe tumor giant cells and the tendency of the tumors to induce osteolysis have led several authors to characterize the multinucleated cells as osteoclasts and classify the tumors as osteoclastomas (7) (8) (9) (10) (11) (12) (13) . Recent evidence suggesting that the multinucleated giant cells are indeed osteoclasts has been provided by Horton et al. (14, 15) , who developed monoclonal antibodies that react with multinucleated cells present in giant cell tumors. These authors suggested (but did not provide proof) that these antibodies recognize cellular antigens that are osteoclast-specific. Because there is considerable evidence that osteoclasts are derived from hematopoietic stem cells of monocyte-macrophage origin (16) (17) (18) , several other investigators have examined cells (both mononuclear and multinucleated) present in giant cell tumors for the presence of Ia and specific granulocyte-monocyte antigens (19) (20) (21) . Although cells expressing monocyte-macrophage phenotype have been identified in the tumors, the precise relationship of these cells to the tumor stromal cells and multinucleated giant cells has not been definitively established.
Our present investigations were therefore undertaken to further characterize the cells present in giant cell tumors and to establish a possible relationship of these cells to other cells of skeletal and connective tissue origin. We previously showed that cells cultured from giant cell tumors increase cAMP when incubated with parathyroid hormone (PTH),' calcitonin (CT), or prostaglandin E2 (PGE2) (21-27). These studies did not permit identification of the individual hormone-responsive cell populations, however. In the present studies we used an autoradiographic technique that enabled us to examine cells cultured from these tumors for the presence of receptors for CT, a hormone believed to act directly on osteoclasts through specific cell surface receptors. The presence of receptors for CT is regarded as a distinctive marker of osteoclast phenotype because other skeletal tissue cells lack receptors for this hormone. In addition, we examined the capacity of cells cultured from these tumors to synthesize and secrete collagen and other high molecular weight proteins. Based on our observations, we conclude that giant cell tumors of bone are neoplasms ofconnective tissue stromal cells, which may have the unique capacity to recruit or interact with multinucleated giant cells possessing receptors for CT and exhibiting other phenotypic features of osteoclasts.
Methods
Tissue preparation and culture procedures. Specimens of tissue from giant cell tumors of bone were obtained at the time of surgery from patients undergoing tumor resection and were kindly provided by Drs. Henry J. Mankin and Mark C. Gebhardt (Orthopaedic Service, Massachusetts General Hospital). Tissues were prepared for culture by dispersion with trypsin-EDTA and clostridial collagenase and cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Grand Island, NY) plus 10% fetal calfserum (FCS) (Bioproducts, Inc., Warrenton, OR) and penicillin 100 U/ml and streptomycin 100 tig/ml (Gibco) as previously described (22, 23) . Tissue samples for what we call fragment culture were cut into small fragments 2-3 mm/diameter and placed in 6-cm-diameter tissue culture dishes (Falcon Labware, Becton, Dickinson & Co., Oxnard, CA). The fragments were teased apart and covered with a drop of culture medium (DMEM, 10% FCS). After 24 h, 2 ml of fresh medium were added and medium changed at 5-7-d intervals.
Hormone incubation. nents synthesized by these cells might to some extent serve as phenotypic markers for establishing the relationship of tumor cells to specific connective tissue cells. Only passaged cells were examined, because it is likely that the cells that proliferated in culture and persisted after passage represented the neoplastic element of the tumor. Fig. 4 shows the patterns of labeled medium proteins under reducing and nonreducing conditions. Several different proteins, including products with mobility characteristic of fibronectin, and fully and partially processed types I and III procollagen were identified. The pattern of collagen types in cells cultured from six different giant cell tumors were qualitatively similar. Although the pattern resembled that seen in dermal fibroblasts, several lower molecular weight species were present, suggesting extensive processing ofthe procollagens. Pepsinization and delayed reduction permitted identification of the alpha 1(I) and the alpha 1(III) collagen chains and established the presence of both types I and III collagen in the medium proteins (Fig. 5) . The ratios of Type I and III collagen were assessed by densitometric scanning of the fluorograms. Ratios of al(I) + a2(I)/al(Ill) ranged from 14.1 to 30.3.
Discussion
In previous studies we showed that a heterogeneous population ofcells could be cultured from human giant cell tumors ofbone, and that the cells in early primary culture exhibited phenotypic tigens. These authors noted that these mononuclear cells differed from mature tissue macrophages by their relatively limited phagocytic activity, the presence of an antigen characteristic of early monocytoid cells, and the absence of a single antigen associated with peripheral blood and tissue macrophages. They suggested that this cell type might be derived from a hematopoietic progenitor related to the mononuclear phagocyte, but representing a cell developing along a pathway distinct from that of monocytes or macrophages. They also described a population of mononuclear cells that were Ia' but failed to express monocyte-macrophage-associated antigens. They speculated that endothelial cells might account for this population. Alternatively, the patterns ofreactivity in the mononuclear cells could reflect the influence oflocal conditions or factors present within Burmester et al. (20) the capacity of these cells to incorporate label into several different high molecular weight proteins including products with mobility on electrophoresis and susceptibility to pepsin characteristic of types I and III collagen. Human macrophages in culture secrete fibronectin but do not produce detectible levels oftypes I or III collagen, (41, 42) , thus providing further evidence that the proliferating cell is not phenotypically related to cells of monocyte-macrophage lineage. Although the pattern of collagen types in cells cultured from tumor tissue resembles that observed in dermal fibroblast cultures, the presence of several low molecular weight species suggests processing of the procollagens. The pattern of processing was highly reproducible in the cells cultured from different tumors and may reflect a distinctive mechanism for processing procollagens.
Unfortunately our studies do not establish the relationship of the proliferating cell to a specific connective tissue cell type. The presence of receptors for PTH is not unique to osteoblasts because we have shown comparable PTH binding and PTHinduced cAMP responses in dermal fibroblasts (26) and synovial fibroblasts (43) . However, the consistent association of tumor stromal cells with cells expressing phenotypic features of osteoclasts suggests that the neoplastic cellular component of this tumor could be related to a cell of skeletal tissue origin which plays a role in the recruitment and formation of osteoclasts. It has been shown that cells related to osteoblasts in the presence of interleukin 1 or PTH have the capacity to stimulate isolated osteoclasts to resorb bone (44) . In conclusion, these tumors may provide a, good model for investigating the ontogeny and differentiation of skeletal tissue cells as well as a system for studying the mechanisms involved in the recruitment and regulation of the biological activity of cells of osteoclast lineage.
